FLT3 and acute myeloid leukemia: BM stromal cells also secrete fibroblast growth factor 2 (FGF2) that binds to FGFR1 in FLT3-ITD AML cells and promotes resistance to FLT3 inhibitors via activation of downstream MAPK pathway [53,54].